At Impact, we are experts in maximizing biosimilar uptake, adoption and market-share growth and maintenance through partnerships with global biosimilars, such as infliximab and adalimumab.
Our experience supporting a wide range of medical and commercial teams to achieve their critical success factors has provided us with a unique depth of expertise to help companies achieve success whatever the market scenario